Research Study on TSC and COVID-19
The TSC Alliance is collecting clinical information about individuals with TSC who had COVID-19 infection. Please circulate to your patients:
The TSC Alliance is collecting clinical information in their TSC Natural History Database about individuals with TSC who had COVID-19 infection. TSC researchers will be using this information to help determine how medications such as everolimus (Afinitor®, Zortress®) or sirolimus (Rapamune®) and other TSC conditions affect the risk of getting COVID-19 and its severity.
If you or your loved one with TSC had COVID-19 confirmed by testing, please consider participating in the TSC Alliance TSC Natural History Database. To get details about participating, please contact Jo Anne Nakagawa at email@example.com or 1-800-225-6872 or 240-638-4654 (direct voicemail). Thank you.